Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age 18-64 Years”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Large-scale testing (Phase 3)Study completedNCT01389479
What this trial is testing

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Who this might be right for
Influenza
GlaxoSmithKline 1,000
Testing effectiveness (Phase 2)WithdrawnNCT01008956
What this trial is testing

Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults

Who this might be right for
Influenza
GlaxoSmithKline
Not applicableStudy completedNCT04664699
What this trial is testing

Randomized Control Trial to Compare Standard Monitoring and Plethysmographic Variability Index-Guided Fluid Therapy In 64 Severe Traumatic Brain Injury Patients, Aged 18 to 60 Years Old Undergoing Emergency Craniotomies

Who this might be right for
Severe Traumatic Brain Injury
Universiti Sains Malaysia 64
Testing effectiveness (Phase 2)Study completedNCT00522067
What this trial is testing

Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.

Who this might be right for
Influenza Disease
Novartis Vaccines 52
Post-approval studies (Phase 4)Study completedNCT03722589
What this trial is testing

Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP

Who this might be right for
Influenza
Centers for Disease Control and Prevention 944
Testing effectiveness (Phase 2)Study completedNCT05975840
What this trial is testing

Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 518
Testing effectiveness (Phase 2)Ended earlyNCT00565799
What this trial is testing

A Pilot Study of Metabolic Effects of Omentectomy

Who this might be right for
Patients Who Consented to Undergo Laparoscopic Gastric Banding Surgery for Weight Loss and Consent to Participate in This studyBMI ≥35 kg/m2Confirmed Type 2 Diabetes Treated With Oral Agents and/or Only Diet TherapyAge 18-64 Years
NYU Langone Health 11
Large-scale testing (Phase 3)Study completedNCT00192192
What this trial is testing

Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults

Who this might be right for
Influenza
MedImmune LLC 20
Large-scale testing (Phase 3)Study completedNCT01712984
What this trial is testing

Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 3,360
Testing effectiveness (Phase 2)Study completedNCT05266456
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults

Who this might be right for
Pneumococcal Vaccines
Vaxcyte, Inc. 835
Large-scale testing (Phase 3)Study completedNCT05310084
What this trial is testing

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 1,134
Testing effectiveness (Phase 2)Study completedNCT00889889
What this trial is testing

Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >= 18 and <= 64, Plus Revaccination

Who this might be right for
Influenza
Abbott Biologicals 1,270
Not applicableStudy completedNCT03694392
What this trial is testing

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

Who this might be right for
InfluenzaPneumoniaLower Respiratory Tract Infection+3 more
Kaiser Permanente 2,776,278
Post-approval studies (Phase 4)Study completedNCT00531596
What this trial is testing

Evaluation of Adhesion and Dermal Tolerability of EMSAM

Who this might be right for
Healthy
Somerset Pharmaceuticals 300
Not applicableStudy completedNCT00791453
What this trial is testing

Clarksdale Diabetes and Metabolism Clinic CHEC Study

Who this might be right for
Diabetes
University of Mississippi Medical Center 55
Testing effectiveness (Phase 2)Study completedNCT00320346
What this trial is testing

Phase II Study of Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Testing effectiveness (Phase 2)Looking for participantsNCT06702449
What this trial is testing

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Who this might be right for
Urinary Tract Infections
GlaxoSmithKline 448
Early research (Phase 1)Study completedNCT05272605
What this trial is testing

Safety and Immune Response of Adjuvanted SARS-CoV-2 (COVID-19) Beta Variant RBD Recombinant Protein (DoCo-Pro-RBD-1 + MF59®) and mRNA (MIPSCo-mRNA-RBD-1) Vaccines in Healthy Adults

Who this might be right for
SARS-CoV-2
University of Melbourne 76
Testing effectiveness (Phase 2)Study completedNCT05175742
What this trial is testing

PTX-COVID19-B, an mRNA Humoral Vaccine, Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Demonstrate the Safety, Tolerability, and Immunogenicity of PTX-COVID19-B in Comparison to the Pfizer-BioNTech COVID-19 Vaccine.

Who this might be right for
Covid19 Vaccine
Providence Therapeutics Holdings Inc. 565
Early research (Phase 1)Study completedNCT01659086
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 422
Load More Results